GovChime
AWARDPURCHASE ORDEROther than small business

Purchase order HT941024P0103BLOODWORKS

Overview

Award facts

Net obligations
$160.22K
$160,221of $1.61M potential value
Period of performance
Feb 27, 2024 to Sep 30, 2026
Ended
Modifications
8
Latest action Dec 31, 2025
Contract type
Purchase order
PIID HT941024P0103

Description of requirement

BLOOD DONOR SCREENING TESTS

Dates and value

Award date
Signed on Feb 27, 2024
Potential end of performance
Sep 29, 2028
Current value
$543,210Base and exercised options
Potential value (if all options are exercised)
$1,613,161

Obligations by fiscal year of action

  • FY2026: -$183,027 (de-obligation)
  • FY2025: $26,209
  • FY2024: $317,039

Total across 3 fiscal years: $160,221

Net de-obligation in that fiscal year (obligations withdrawn).

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 15, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 31, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameBLOODWORKS
LocationSEATTLE, WA
UEIZN56PFWUDQK7
CAGE code44701
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyBLOODWORKS

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Defense Health Agency
  3. DEFENSE HEALTH AGENCY HCD WEST
Funded by
  1. Department of Defense
  2. Defense Health Agency
  3. USNAV HOSPITAL OKINAWA - MM
Funded from
Operation and maintenanceProgram activities097-0130Federal accounts (agency financial reports)

Place of performance

Place of performance
Seattle, King County, Washington 98104-1239
Congressional district (place of performance)
WA-07As reported at the time of the action

Classification and competition

Classification

NAICS
325413IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Product or service (PSC)
6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (product)

Competition

Extent competed
Competed under SAPF
Solicitation procedures
Simplified acquisitionSP1
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
2

Solicitation and notices

Solicitation ID
HT941024Q2024
Solicitation date
Feb 20, 2024
Notices

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No

Transaction history

Modification history

Base award
Feb 27, 2024Base obligation at award: $109,239
Latest action
Dec 31, 2025 — Supplemental agreement (within scope)Modification P00010; obligation change -$183,027
Latest substantive action
Dec 31, 2025 — Supplemental agreement (within scope)Modification P00010; obligation change -$183,027
Latest funding action
Jan 28, 2025 — Funding onlyModification P00006; obligation change +$265,191; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)7
  • Funding only1
9 actions recorded, Feb 27, 2024 to Dec 31, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
Yes

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$426,769
Latest action: change in base and all options
-$426,769

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Meets requirementsA
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D

Structure

Award or IDV
Award
Award type
Purchase orderB
IT commercial item category
Not IT products or servicesZ
Awarding agency code
9700
Awarding sub-tier code
97DH
Contracting office code
HT9410
Transactions recorded under this award key
9

Funding

Funding agency code
9700
Funding sub-tier code
97DH
Funding office code
HT0720
Treasury accounts
  • 097-2024/2024-0130-000
Object classes
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression